Cargando…
Trial watch: Peptide vaccines in cancer therapy
Prophylactic vaccination constitutes one of the most prominent medical achievements of history. This concept was first demonstrated by the pioneer work of Edward Jenner, dating back to the late 1790s, after which an array of preparations that confer life-long protective immunity against several infe...
Autores principales: | Vacchelli, Erika, Martins, Isabelle, Eggermont, Alexander, Fridman, Wolf Hervé, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525611/ https://www.ncbi.nlm.nih.gov/pubmed/23264902 http://dx.doi.org/10.4161/onci.22428 |
Ejemplares similares
-
Trial Watch: Peptide vaccines in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2013) -
Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012) -
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012) -
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012) -
Trial watch: Dendritic cell-based interventions for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)